Department of Pediatrics, University of Illinois at Chicago, Chicago, IL, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Cell Signal. 2017 Oct;38:49-59. doi: 10.1016/j.cellsig.2017.06.016. Epub 2017 Jun 24.
Atypical protein kinase C ζ (PKCζ) forms an apico-basal polarity complex with Partitioning Defective (Pard) 3 and Pard6 to regulate normal epithelial cell apico-basolateral polarization. The dissociation of the PKCζ/Pard3/Pard6 complex is essential for the disassembly of the tight/adherens junction and epithelial-mesenchymal transition (EMT) that is critical for tumor spreading. Loss of cell polarity and epithelial organization is strongly correlated with malignancy and tumor progression in some other cancer types. However, it is unclear whether the PKCζ/Pard3/Pard6 complex plays a role in the progression of non-small-cell lung cancer (NSCLC). We found that hypoxia downregulated the PKCζ/Pard3/Pard6 complex, correlating with induction of lung cancer cell migration and invasion. Silencing of the PKCζ/Pard3/Pard6 polarity complex components induced lung cancer cell EMT, invasion, and colonization in vivo. Suppression of Pard3 was associated with altered expression of genes regulating wound healing, cell apoptosis/death and cell motility, and particularly upregulation of MAP3K1 and fibronectin which are known to contribute to lung cancer progression. Human lung adenocarcinoma tissues expressed less Pard6b and PKCζ than the adjacent normal tissues and in experimental mouse lung adenocarcinoma, the levels of Pard3 and PKCζ were also decreased. In addition, we showed that a methylation locus in the gene body of Pard3 is positively associated with the expression of Pard3 and that methylation of the Pard3 gene increased cellular sensitivity to carboplatin, a common chemotherapy drug. Suppression of Pard3 increased chemoresistance in lung cancer cells. Together, these results suggest that reduced expression of PKCζ/Pard3/Pard6 contributes to NSCLC EMT, invasion, and chemoresistance.
非典型蛋白激酶 C ζ (PKCζ) 与 Partitioning Defective (Pard) 3 和 Pard6 形成一个顶-基底极性复合物,以调节正常上皮细胞的顶-基底极性。PKCζ/Pard3/Pard6 复合物的解离对于紧密/黏附连接的解体和上皮-间充质转化 (EMT) 至关重要,EMT 对于肿瘤的扩散是关键的。细胞极性和上皮组织的丧失与某些其他癌症类型的恶性肿瘤和肿瘤进展密切相关。然而,PKCζ/Pard3/Pard6 复合物是否在非小细胞肺癌 (NSCLC) 的进展中发挥作用尚不清楚。我们发现缺氧下调了 PKCζ/Pard3/Pard6 复合物,与肺癌细胞迁移和侵袭的诱导相关。沉默 PKCζ/Pard3/Pard6 极性复合物的成分诱导肺癌细胞 EMT、侵袭和体内定植。Pard3 的抑制与调节伤口愈合、细胞凋亡/死亡和细胞迁移的基因表达的改变相关,特别是 MAP3K1 和纤维连接蛋白的上调,已知它们有助于肺癌的进展。人肺腺癌组织中 Pard6b 和 PKCζ 的表达低于相邻的正常组织,在实验性小鼠肺腺癌中,Pard3 和 PKCζ 的水平也降低了。此外,我们还表明 Pard3 基因体中的一个甲基化位点与 Pard3 的表达呈正相关,并且 Pard3 基因的甲基化增加了细胞对卡铂的敏感性,卡铂是一种常用的化疗药物。Pard3 的抑制增加了肺癌细胞的化疗耐药性。综上所述,PKCζ/Pard3/Pard6 的表达降低导致 NSCLC EMT、侵袭和化疗耐药。